LRF Scientific Advisory Board Members Joined by Current and Former Grantees at the 61st ASH Annual Meeting & Exposition
NEW YORK (PRWEB) DECEMBER 05, 2019
The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community – will return to the American Society of Hematology (ASH) Annual Meeting and Exposition, with nearly 70 LRF-affiliated scientists presenting more than 100 abstracts at this year’s conference.
Widely regarded as the premier event in malignant and non-malignant hematology, the ASH Annual Meeting, taking place December 7-10, 2019 in Orlando, FL, provides a critical forum for leading hematologists /oncologists to present their findings to over 20,000 of their peers. Among the distinguished scientists invited to present, nearly 50 percent of LRF Scholars – participants in LRF’s Lymphoma Clinical Research Mentoring Program (LCRMP) – will present abstracts at the 2019 meeting.
In addition to the Foundation’s representation through presentations, more than 60 percent of LRF grantees from the past decade are authors on abstracts selected for this year’s meeting alone. In addition, LRF is represented in more than 770 abstracts through grantees, Lymphoma RoundsSteering Committee members, Mantle Cell Lymphoma (MCL) Consortium members, LRF staff, and current and former Scientific Advisory Board (SAB) members.
“The fact that we have 98 percent of LRF’s current Scientific Advisory Board members involved in abstracts at this year’s ASH Annual Meeting speaks to the caliber of world-leading scientists we have steering LRF’s research investment and patient education,” said Andrew D. Zelenetz, MD, PhD, Chair of the LRF Scientific Advisory Board. “As Chair of this prestigious board, I am encouraged and proud of the incredible research being presented by the early career scientists we support.”
The 2019 ASH Annual Meeting also featured 15 abstracts and presentations stemming from current LRF-funded research.
“We are incredibly proud to support scientists who are making strides in advancing lymphoma research,” said Meghan Gutierrez, Chief Executive Officer of the Lymphoma Research Foundation. “The Foundation is grateful for the expertise of our Scientific Advisory Board which guides our research investment, so that we can continue to make a meaningful impact on the future of lymphoma research, which is evident in the number of young investigators supported by LRF presenting at this year’s ASH annual meeting.”
Throughout each ASH Annual Meeting, members of the Lymphoma Research Foundation Executive Team will be available for comment on ongoing ASH presentations and findings. For requests for comment, please contact Kinya Harte, Director of Communications and Marketing at [email protected] or 646-465-9107.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $62 million in lymphoma-specific research. For additional information on LRF’s research, education and services, visit lymphoma.org.
The fact that we have 98 percent of LRF’s current Scientific Advisory Board members involved in abstracts at this year’s ASH Annual Meeting speaks to the caliber of world-leading scientists we have steering LRF’s research investment and patient education